| DG02919 | |
| DG number | DG02919 |
| Classification | DGroup |
| Name | CYP2B6 substrate TYPE Metabolism |
| Stem | - |
| Structural formula | ![]() |
| Member | DG03104 Vonoprazan D11784 Vonoprazan (USAN/INN) D10466 Vonoprazan fumarate (JAN/USAN) D10775 Vonoprazan, amoxicillin and clarithromycin D10774 Vonoprazan, amoxicillin and metronidazole DG00103 Fenfluramine D07945 Fenfluramine (INN) D04148 Fenfluramine hydrochloride (JAN/USAN) DG00155 Clopidogrel D07729 Clopidogrel (USP/INN) D00769 Clopidogrel bisulfate (USP); Clopidogrel sulfate (JP18); Clopidogrel sulfate tablets (JP18) D10823 Clopidogrel hydrochloride D10824 Clopidogrel besilate D10513 Clopidogrel sulfate and aspirin D11330 Voxelotor (USAN) DG02839 Osilodrostat D11061 Osilodrostat (USAN/INN) D11062 Osilodrostat phosphate (JAN/USAN) D00435 Nevirapine (JAN/USP/INN) D00896 Efavirenz (JAN/USP/INN) D10827 Sofosbuvir and velpatasvir D11521 Lamivudine, nevirapine and zidovudine DG00675 Cyclophosphamide D07760 Cyclophosphamide (INN) D00287 Cyclophosphamide (USP); Cyclophosphamide hydrate (JP18) D11817 Deucravacitinib (JAN/USAN) DG01829 Esketamine D07283 Esketamine (USAN/INN) D10627 Esketamine hydrochloride (JAN/USAN) D03844 Phenytoin, phenobarbital and caffeine and sodium benzoate D11150 Cenobamate (USAN/INN) D04300 Ganaxolone (USAN/INN) DG00864 Selegiline D03731 Selegiline (USAN/INN) D00785 Selegiline hydrochloride (JAN/USP) DG00945 Sertraline D02360 Sertraline (INN) D00825 Sertraline hydrochloride (JAN/USP) DG00965 Vortioxetine D10184 Vortioxetine (USAN) D10185 Vortioxetine hydrobromide (JAN/USAN) D12544 Vortioxetine hemihydrobromide (USAN) DG00999 Methadone D08195 Methadone (BAN) D02102 Methadone hydrochloride (JAN/USP) DG01075 Hydrocodone D08045 Hydrocodone (INN) D03725 Hydrocodone bitartrate (USP) D04461 Hydrocodone polistirex (USAN) D08046 Hydrocodone hydrochloride D10512 Brinzolamide and timolol maleate DG01333 Sarpogrelate D08508 Sarpogrelate (INN) D01624 Sarpogrelate hydrochloride (JP18) |
| Upper group | Metabolizing enzyme substrate |
| Remark | - |
| Comment | - |